Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Work In Process (2019 - 2025)

Pulmonx has reported Work In Process over the past 7 years, most recently at $529000.0 for Q4 2025.

  • Quarterly Work In Process rose 15.75% to $529000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $529000.0 through Dec 2025, up 15.75% year-over-year, with the annual reading at $529000.0 for FY2025, 15.75% up from the prior year.
  • Work In Process was $529000.0 for Q4 2025 at Pulmonx, down from $577000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $784000.0 in Q2 2022 and troughed at $313000.0 in Q1 2021.
  • The 5-year median for Work In Process is $510500.0 (2021), against an average of $514600.0.
  • Year-over-year, Work In Process skyrocketed 139.62% in 2022 and then plummeted 39.15% in 2024.
  • A 5-year view of Work In Process shows it stood at $518000.0 in 2021, then decreased by 25.48% to $386000.0 in 2022, then increased by 10.62% to $427000.0 in 2023, then increased by 7.03% to $457000.0 in 2024, then rose by 15.75% to $529000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Work In Process are $529000.0 (Q4 2025), $577000.0 (Q3 2025), and $562000.0 (Q2 2025).